Skip to main
SEPN
SEPN logo

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc., with a current enterprise value of approximately $430 million, has significant long-term growth potential driven by its proprietary Native Complex Platform, which enhances the development of GPCR therapies. The company is positioned for success with its promising pipeline candidates, especially SEP-631, which could achieve blockbuster status if it replicates the efficacy of Xolair, thereby opening avenues for substantial revenue generation. Additionally, management’s experience with SEP-786 is expected to enhance the efficiency of Phase 1 trials for its candidates, indicating the potential for improved clinical outcomes and accelerated timelines in drug development.

Bears say

Septerna Inc faces significant risks that could adversely impact its stock performance, including potential delays in advancing its clinical candidates such as SEP-631, along with the possibility of setbacks in clinical trials. The company's partnership with Novo Nordisk presents additional uncertainties, and the risk of failing to secure approvals for its key candidates could hinder its market entry. Furthermore, challenges such as lower-than-expected market penetration rates and potential long-term dilution add to the negative outlook on the company's financial prospects, particularly in light of a recent transaction in the obesity sector that highlights a valuation gap.

Septerna Inc (SEPN) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Buy based on their latest research and market trends.

According to 3 analysts, Septerna Inc (SEPN) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.